Management of inflammatory bowel disease with Clostridium difficile infection Review uri icon

Overview

MeSH Major

  • Anti-Bacterial Agents
  • Clostridium Infections
  • Clostridium difficile
  • Glucocorticoids
  • Immunologic Factors
  • Inflammatory Bowel Diseases

abstract

  • Strong recommendations regarding when to initiate IBD specific therapy in those with CDI are precluded by a lack of evidence. However, based on expert opinion and observational data, initiation or resumption of immunosuppressive therapy after 48-72 h of targeted antibiotic treatment for CDI may be considered.

publication date

  • July 21, 2017

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC5526769

Digital Object Identifier (DOI)

  • 10.3748/wjg.v23.i27.4986

PubMed ID

  • 28785153

Additional Document Info

start page

  • 4986

end page

  • 5003

volume

  • 23

number

  • 27